Report overview
This report contains market size and forecasts of Hydroxychloroquine Sulfate in global, including the following market information:
Global Hydroxychloroquine Sulfate Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Hydroxychloroquine Sulfate Market Sales, 2017-2022, 2023-2028, (MT)
Global top five Hydroxychloroquine Sulfate companies in 2021 (%)
The global Hydroxychloroquine Sulfate market was valued at 904.9 million in 2021 and is projected to reach US$ 1023.8 million by 2028, at a CAGR of 1.8% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
USP Standards Grade Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Hydroxychloroquine Sulfate include Sandoz, TEVA, Mylan, HIKMA, IPCA, Jiangsu Shenhua Pharmaceutical, Sanofi, TAJ Pharma and Shanghai Zhongxisanwei and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Hydroxychloroquine Sulfate manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Hydroxychloroquine Sulfate Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (MT)
Global Hydroxychloroquine Sulfate Market Segment Percentages, by Type, 2021 (%)
USP Standards Grade
EP Standards Grade
Pharmaceutical Standards Grade
Others
Global Hydroxychloroquine Sulfate Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (MT)
Global Hydroxychloroquine Sulfate Market Segment Percentages, by Application, 2021 (%)
Rheumatoid Joint
Adolescent Chronic Joint
Discoid and Systemic Lupus Erythemato Sus
Skin Lesions
Global Hydroxychloroquine Sulfate Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (MT)
Global Hydroxychloroquine Sulfate Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Hydroxychloroquine Sulfate revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Hydroxychloroquine Sulfate revenues share in global market, 2021 (%)
Key companies Hydroxychloroquine Sulfate sales in global market, 2017-2022 (Estimated), (MT)
Key companies Hydroxychloroquine Sulfate sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Sandoz
TEVA
Mylan
HIKMA
IPCA
Jiangsu Shenhua Pharmaceutical
Sanofi
TAJ Pharma
Shanghai Zhongxisanwei
Wuhan Wuyao Pharmaceutical
